💡 Use & Benefits

• Treats partial-onset seizures, with or without secondary generalization

• Used in myoclonic seizures (juvenile myoclonic epilepsy) and idiopathic generalized tonic–clonic seizures 

• Suitable for monotherapy (adults/adolescents 16+) or as adjunctive therapy (children ≥ 1 month) 

• Known for high oral bioavailability and favorable drug interaction profile—does not affect other antiepileptics and vice versa